Saturday, July 11, 2026

Drug profile · INN

vosaroxin

vosaroxin (QINPREZO) is a dna topoisomerase ii inhibitor.

EMA: application withdrawn Antineoplastic and immunomodulating agents (L01) L01
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — vosaroxin
Class
Antineoplastic and immunomodulating agents (L01)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

vosaroxin (QINPREZO) is a dna topoisomerase ii inhibitor.

Key facts

INN vosaroxin
Brand QINPREZO
Mechanism DNA topoisomerase II inhibitor
Target DNA
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01

Mechanism of action

DNA topoisomerase II inhibitor

Primary target: DNA

Approval history

Authority Status Date
EMA application withdrawn

Related & competitor drugs

  1. abiraterone acetate Antineoplastic and immunomodulating agents (L02)
  2. acyclovir Human herpesvirus 1 DNA polymerase inhibitor
  3. acyclovir sodium Human herpesvirus 1 DNA polymerase inhibitor
  4. anagrelide Antineoplastic and immunomodulating agents (L01)
  5. apremilast Antineoplastic and immunomodulating agents (L04)
  6. arsenic trioxide Antineoplastic and immunomodulating agents (L01)

Frequently asked questions

What is vosaroxin?

vosaroxin (QINPREZO) is a dna topoisomerase ii inhibitor.

What is the brand name for vosaroxin?

QINPREZO is a marketed brand name for vosaroxin. Check FDA Drugs@FDA for the current US label holder and prescribing information.